Objective  To conduct a visual analysis of the relevant literature in the field of Dai medicine research from 2014 to 2024 based on CiteSpace software, comprehensively summarize and display the status quo, hotspots and development trends of Dai medicine research in the past decade, and provide scientific basis for the in-depth development and international dissemination of Dai medicine research.

Methods  The literature related to Dai medicine research was searched and screened in CNKI for bibliometric analysis. The annual number of publications, authors, institutions, keywords and mutation words were analyzed to identify research hotspots and frontiers, and explore new trends and potential breakthrough points of Dai medicine research.

Results  From 2014 to 2024, the annual number of publications in Dai medicine research exhibited a fluctuating trend, initially rising and then declining. A total of 274 authors participated in the research, among which Chen Qinghua (n=19) published the most papers. The study involved 246 institutions, mainly including Yunnan University of Chinese Medicine and Xishuangbanna Dai Medical Hospital, indicating the dominant position of Yunnan Province in Dai medicine research. The keywords included ethnomedicine, chemical components, clinical application, research progress, content determination, etc., focusing on topics such as chemical components and pharmacological effects, clinical disease treatment, consensus and development of ethnomedicine, data mining and association rules, and specific theories and applications of Dai medicine. Moreover, Folium Alstoniae Scholaris, Clerodendranthus spicatus, and Zingiber montanum were the emergence keywords of significant drugs in the research.

Conclusion  This study revealed the development pattern of Dai medicine research in the past decade through visual analysis based on CiteSpace, and provided a reference for the promotion of traditional medicine worldwide.

1.孔春芹. 贝叶经中的傣族医药文化[J]. 中国民族民间医药, 2022, 31(12): 1-4. [Kong CQ. The medicine culture of Dai nationality in Bei Ye scripture[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2022, 31(12): 1-4.] DOI: 10.3969/j.issn.1007-8517.2022.12.zgmzmjyyzz202212002.

2.赵晨勋, 段忠玉. 云南跨境少数民族医药文化的传承困境分析[J]. 中国民族民间医药, 2022, 31(7): 1-4. [Zhao CX, Duan ZY. Research on the inheritance dilemma of cross-border ethnic minority medical culture in Yunnan[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2022, 31(7): 1-4.] DOI: 10.3969/j.issn.1007-8517.2022.7.zgmzmjyyzz202207002.

3.云南省中医药学会风湿病专业委员会, 云南省中西医结合学会风湿类疾病专业委员会, 云南省民族民间医药学会. 傣医防治拢沙候(痛风)专家共识[J]. 中国民族民间医药, 2022, 31(8): 1-4. [Yunnan Association of Traditional Chinese Medicine Rheumatology Committee, Yunnan Association of Integrated Traditional Chinese and Western Medicine Rheumatology Committee, Yunnan Provincial National Folk Medicine Association. Expert consensus on Dai medicine prevention and treatment of Lonsahou (gout)[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2022, 31(8): 1-4.] DOI: 10.3969/j.issn.1007-8517.2022.8.zgmzmjyyzz202208002.

4.张国庆, 李亦学, 王泽峰, 等. 生物医学大数据发展的新挑战与趋势[J]. 中国科学院院刊, 2018, 33(8): 853-860. [Zhang GQ, Li YX, Wang ZF, et al. New challenges and trends in bio-med big data[J]. Bulletin of Chinese Academy of Sciences, 2018, 33(8): 853-860.] DOI: 10.16418/j.issn.1000-3045.2018.08.013.

5.Koh A, Lewis-Lloyd CA, Wong T, et al. Correlation between Altmetric Attention Scores and citation scores across the high impact-factor journals each in Medicine, Surgery, and Anaesthesia[J]. Br J Anaesth, 134(3): 703-712. DOI: 10.1016/j.bja.2024.09.034.

6.Wu Z, Zhang Y, Gong Y, et al. Knowledge landscape of Treg research in breast cancer: a bibliometric and visual analysis[J]. Front Oncol. 2024, 14: 1448714. DOI: 10.3389/fonc.2024.1448714.

7.杨丽萍, 熊竞争, 陈清华, 等. 基于OBE理念的傣医方剂学临床实训课程教学探究[J]. 基层中医药, 2024, 3(7): 70-75. [Yang  LP, Xiong JJ, Chen QH, et al. Research on clinical training course of Dai medicine formulas based on OBE concept[J]. Basic Traditional Chinese Medicine, 2024, 3(7): 70-75.] DOI: 10.20065/j.cnki.btcm.20240129.

8.王雪梅, 李媛, 金羽, 等. 基于傣医学经筋理论的特色诊法探析[J]. 亚太传统医药, 2023, 19(12): 95-98. [Wang XM, Li Y, Jin Y, et al. Experimental diagnosis method based on the meridian tendon theory of Dai medicine with special features[J]. Asia-Pacific Traditional Medicine, 2023, 19(12): 95-98.] DOI: 10.11954/ytctyy.202312017.

9.王雪梅, 陈清华, 陈蓉, 等. 傣医“经筋-四塔-脏腑”辨证思路探讨[J]. 中华中医药杂志, 2023, 38(10): 4806-4809. [Wang XM, Chen QH, Chen R, et al. Discussion on the identification ideas of "meridian tendons-four pagoda-viscera" in Dai medicine[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2023, 38(10): 4806-4809.] https://d.wanfangdata.com.cn/periodical/Ch9QZXJpb2RpY2FsQ0hJTmV3UzIwMjUwMTE2MTYzNjE0Eg96Z3l5eGIyMDIzMTAwNjQaCDFtZHJzZTYy

10.熊竞争, 李翔, 陈博, 等. 傣医药治疗皮肤病研究进展[J]. 中华中医药杂志, 2023, 38(10): 4861-4865. [Xiong JJ, Li X, Chen  B, et al. Research progress of Dai medicine in the treatment of skin diseases[J]. Chinese Journal of Traditional Chinese Medicine and Pharmacology, 2023, 38(10): 4861-4865.] https://d.wanfangdata.com.cn/periodical/Ch9QZXJpb2RpY2FsQ0hJTmV3UzIwMjUwMTE2MTYzNjE0Eg96Z3l5eGIyMDIzMTAwNzYaCHE4b2twcXkz

11.Guo R, Shang JH, Ye RH, et al. Pharmacological investigation of indole alkaloids from Alstonia scholaris against chronic glomerulonephritis[J]. Phytomedicine, 2023, 118: 154958. DOI: 10.1016/j.phymed.2023.154958.

12.Wang Y, Li K, Yan S, et al. Clerodendranthus spicatus [Orthosiphon aristatus (Blume) Miq.] maintains uric acid homeostasis via regulating gut microbiota and restrains renal inflammation in hyperuricemic nephropathy[J]. Front Pharmacol, 2024, 15: 1485861. DOI: 10.3389/fphar.2024.1485861.

13.倪凯, 赵远, 林艳芳, 等. 傣医外治法中果雅的治法方药探讨 [J]. 云南中医中药杂志, 2014, 35(11): 86-87. [Ni K, Zhao  Y, Lin  YF, et al. Discussion on the therapeutic methods and prescriptions of Guoya in external therapy of Dai medicine[J]. Yunnan Journal of Traditional Chinese Medicine and Materia Medica, 2014, 35(11): 86-87.] DOI: 10.16254/j.cnki.53-1120/r.2014.11.036.

14.李忠华, 刀会仙, 谭志刚. 傣医拖擦药物疗法治疗拢梅兰申60例临床观察[J]. 中国民族民间医药, 2014, 23(16): 10. [Li ZH, Dao HX, Tan ZG. Clinical observation on 60 cases of Long Meilanshen treated by drag-wipe drug therapy of Dai medicine[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2014, 23(16): 10.] DOI: 10.3969/j.issn.1007-8517.2014.16.zgmzmjyyzz201416007.

15.廖国荣. 浅谈傣医药发展的文化困境及其解决策略[J]. 医学食疗与健康, 2020, 18(11): 202, 205. [Liao GR. Discussion on the cultural dilemma of Dai medicine development and its solutions[J]. Medical Diet and Health, 2020, 18(11): 202, 205.] https://www.cqvip.com/doc/journal/933885926?sign=75b5236921a3a1cbe1bb022396971f4f54fd689c580da79f9115e26adefa6241&expireTime=1741660004193&resourceId=933885926

16.胡粉青, 邵曰凤, 邹澄. 德宏傣族医药现状及发展思考 [J]. 中国民族民间医药, 2019, 28(1): 4-6. [Hu FQ, Shao YF, Zou  C. Thinking about current situation and development of Dai medicine in Dehong[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2019, 28(1): 4-6.] DOI: 10.3969/j.issn.1007-8517.2019.1.zgmzmjyyzz201901004.

17.刘世芳, 李宜航, 苏晶, 等. 傣药鲜药的应用现状及开发前景 [J]. 亚太传统医药, 2022, 18(8): 11-15. [Liu SF, Li YH, Su  J, et al. Present research situation and application prospect of Dai fresh medicines[J]. Asia-Pacific Traditional Medicine, 2022, 18(8): 11-15.] DOI: 10.11954/ytctyy.202208003.

18.Wang MY, Mo XY, Yi MX, et al. Visualization of the relationship between metabolism and lung diseases from the perspective of bibliometric analysis: research trends and future prospects[J]. Front Med (Lausanne), 2024, 11: 1443926. DOI: 10.3389/fmed.2024.1443926.